PUBLISHER: The Insight Partners | PRODUCT CODE: 1007278
PUBLISHER: The Insight Partners | PRODUCT CODE: 1007278
The Europe biomedical sensors market is expected to reach US$ 4,407.9 million by 2027 from US$ 2,552.4 million in 2019. The market is estimated to grow at a CAGR of 7.1% during 2020-2027.
The growth of the Europe biomedical sensors market is attributed to the key driving factors such as the rising incidence of lifestyle-based diseases and an increasing adoption of biomedical sensors. However, the security concerns regarding the use of biomedical sensors hinder the market growth.
Biomedical sensors are used in various medical and biotechnology practices to detect biological, chemical, or physical processes and transmit the data. Additionally, these sensors are used in the medical areas ranging from temperature sensors, pressure detectors, acoustic sensors, flow sensors, and gas sensors to cameras, image sensors, and magnetic field sensors. Image sensors and cameras used in the medical sector include X-ray, optical, and ultrasonic. Biomedical sensors are also used to monitor the safety of medicines, food, environmental conditions, and other substances. Moreover, the sensors have a rising demand in IT. Numerous awareness programs have been organized by governmental organizations to control and prevent diseases. For instance, the National Heart Disease and Stroke Prevention Program and Lipid Standardization Program are conducted by Centre for Disease Control and Prevention (CDC) to create awareness among the population. These programs consist of trainings and campaigns to spread awareness regarding the ill effects of cholesterol; also, provide education to the hospital staffs. Thus, the rising incidence of lifestyle-based diseases are driving the market growth in Europe.
Reliable and timely COVID-19 testing is an integral part of the monitoring, prevention, touch recording, infections control, and clinical management of COVID-19. For instance, an ERDF-funded project is helping to tackle the COVID-19 crisis in Italy. New sensors created by the MEDIWARN project allow healthcare staff to monitor patients suffering from the disease at a distance. The biosensors can monitor a patient's vital signs such as heartbeat, respiratory rate, blood pressure, and body temperature. It is difficult and dangerous for medical and nursing staff to monitor COVID-19 patients in person. Infected and symptomatic patients need to be isolated in rooms with negative pressure. The new sensors allow staff to easily monitor such patients from another room. Thus, COVID-19 pandemic resulted in increasing demand for healthcare monitoring and awareness, which is boosting the biomedical sensors market.
Based on type, the Europe biomedical sensors market is bifurcated into wired and wireless. The wireless segment held a larger market share in 2019, also the same segment is anticipated to register a higher CAGR in the market during the forecast period.
Based on sensor type, the Europe biomedical sensors market is segmented into temperature, pressure, image sensors, biochemical, inertial sensors, motion sensors, electrocardiogram (ECG), and other sensor types. The temperature segment held the largest market share in 2019, whereas the motion sensors segment is anticipated to register the highest CAGR in the market during 2020-2027.
The Europe biomedical sensors market, by product, is bifurcated into invasive sensors and non-invasive sensors. The non-invasive sensors segment held a larger market share in 2019, also the same segment is anticipated to register a higher CAGR in the market during the forecast period.
By application, the Europe biomedical sensors market is segmented into medical diagnostics, clinical therapy, imaging, and personal healthcare. The medical diagnostics segment held the largest market share in 2019, whereas the personal healthcare segment is anticipated to register the highest CAGR in the market during 2020-2027.
A few of the primary and secondary sources referred to while preparing the report on the Europe biomedical sensors market are the European Cardiovascular Disease Statistics (2017) and National Health System of Spain (NHS).